F.D.A. Allows First Use of a Novel Cancer Drug This is very good news.. first we get access to a new class of drugs - PD-1 inhibitors. Next - the FDA showed that they understand the cancer community's needs and approved this after only a phase 1 trial. This could open the floodgates for FDA approval of new cancer treatments as there are a few brain cancer treatments in the pipeline that will soon be reporting phase 2 results. IF the results are good enough, perhaps we can get them approved without having to wait a few more years for phase 3 to complete.
This also raises the possibility of combinations of treatments such as adding a CTLA-4 inhibitor such as Yervoy and another drug or 2 - perhaps Avastin.
